PE(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
|
Basic information |
| Metabolite name | PE(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) |
 | HMDB0008946 |
 |
C00350 |
 |
9546799 |
| Synonyms | NA |
| No. of studies | 4 |
|
Basic information |
| Metabolite name | PE(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) |
| HMDB0008946 |
|
C00350 |
|
9546799 |
| Synonyms | NA |
| No. of studies | 4 |
|
Relationship between PE(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) and depression (count: 4) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M1011 | Type1 | lipopolysaccharide group vs. control group | Medial prefrontal cortex | Sprague-Dawley rat | Up |
| Study M1053 | Type1 | CUMS group vs. control group | Liver | Sprague-Dawley rat | Up |
| Study M1053 | Type2 | CUMS + quercetin group vs. CUMS group | Liver | Sprague-Dawley rat | Down |
| Study M460 | Type1 | depressed group vs. control group | Liver | Kunming mouse | Up |
| Study M687 | Type1 | depression group vs. control group | Serum | Human | Down |